Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Life Science R&D Big Data Leaders Forum

03 Dec 2013 - 05 Dec 2013 - Ramada Plaza Basel, Switzerland



Bookmark and Share


This 3 day forum is the “must attend” event for those senior decision-makers looking to make the shift towards big data and for those looking to improve their implementation of data-driven approaches for their specific departments.

The first day will feature several keynote presentations from C-Level thought leaders on big data in the R&D space and heads of major research institutions who are at the front-end of the big data challenge. They will be discussing the strategic drivers for big data and key implementation guidance on how to make best use of this approach.

Day 2&3 of the Forum will feature 3 specific streams depending on the phase of R&D that is most crucial for you:

-              Discovery & Translational Big Data Forum;

-              Clinical Data Management Forum;

-              Real-World & Health Outcomes Big Data Forum.

Discovery & Translational Big Data Forum will be focusing on important issues related to use of big data to support various functions within the drug discovery process, including better designing NMEs, re-engineering and re-initiating previously failed drug programs and will enable participants to make the most informed decisions possible on how to enhance the management and application of their discovery and translational data. Clinical Data Management Forum will explore a number of areas vital to the development of clinical data management (CDM) and present key issues in selecting and implementing a CDM system. Real-World & Health Outcomes Big Data Forum will discover how to best design observational studies to get most of the real world data generated, what are the new and innovative approaches to capture, store and manage as well as what is the role of evidence and health outcomes data in decision-making.

To request the full agenda please follow the link:

http://bigdata2013.nextlevelpharma.com/request-agenda

Erika Vavrovicova

Life science Big Data Leaders Forum

Tel: +421 232 660 382

Fax: +421 2 3301 0331
Email: erika@nextlevellifesciences.com

Visit: bigdata2013.nextlevelpharma.com



Further information
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!